Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sanofi Looking for China M&A to Increase Revenue

publication date: Apr 1, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sanofi SA is actively seeking China M&A opportunities in the consumer healthcare and veterinary products sectors, according to the company’s CEO, Christopher Viehbacher, who was quoted in a Wall Street Journal article. The French big pharma wants to produce double-digit revenue growth in China during each of the next five years. Its China revenues were $1.3 billion last year, a 15% increase over the previous year. More details....

Stock Symbol: (NYSE: SNY)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners